- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- News News
- Join Join
Chelsea McDougall, Northwest Herald
The federal government is considering easing its position on marijuana, reclassifying it as a less dangerous drug in what marijuana advocates say reflects the changing attitudes nationwide.
But drug specialists fear the watershed moment for marijuana research could be a slippery slope for addicts.
The Food and Drug Administration is reviewing marijuana’s classification to consider changing it from a Schedule I drug.
The feds classify drugs in five stages, with Schedule I reserved for the most dangerous drugs with the highest potential for abuse and dependence, and those with no currently accepted medical use.
Other Schedule I heavy hitters include heroin, ecstasy and LSD.
Cocaine and methamphetamine fall into Schedule II drugs.
Paul Armentano specializes in issues regarding the science and research of marijuana at NORML, or National Organization for the Reform of Marijuana Laws. He argues that marijuana doesn’t even hold a candle to the other drugs it’s classified with.
“Marijuana is not a harmless substance,” he said. “But, it’s potential risks to the individual and to society do not warrant its present Schedule I illicit status under federal law.”
Health concerns, he said, would best be addressed by regulation, age restrictions and public education.
Although a reclassification wouldn’t make marijuana legal, it could open doors for more medical marijuana research, advocates say.
“The biggest reason that we’re not able to do more with medical cannabis is because of its Schedule I classification,” said Julie Dohm, chairperson of the Illinois chapter of Americans for Safe Access, or ASA, an organization promoting medical marijuana research and therapeutic uses.
“The FDA and DEA keeping saying that [marijuana] has no medical purpose or that it’s dangerous – that’s just false,” Dohm continued. “There are plenty of studies from other countries that can do the types of trials that we can’t here. ... Studies saying it has a medical benefit and it’s a lot safer than a lot of the other drugs we allow people to take.”
At the request of the DEA in 2001 and again in 2006, the FDA conducted a review of the available data for marijuana, and both times recommended that marijuana remain a Schedule I, because of its high potential for abuse, and the fact that it has no accepted medical uses.
However, the determination of whether or not a drug has “accepted medical use” is its FDA approval, Armentano said.
“So one can infer that as long as marijuana remains non-FDA approved, then the agency will affirm its Schedule I classification,” Armentano said.
But Dohm believes this time is different, and she pointed to the 23 states, including Illinois, that have approved marijuana for medical use, with several others considering it. Two states – Colorado and Washington – have approved marijuana for recreational use.
Still, for local substance abuse counselors like McHenry County-based Rick Atwater, the changing laws could send the wrong message. The message that marijuana is harmless simply isn’t true, he said.
“Regardless of how the FDA reclassifies it or if the state says we can use it for certain medical conditions, it’s still not a legal drug and it’s not OK to use it,” Atwater said. “That message isn’t being heard very loudly.
“… [It] doesn’t change the fact that it’s dangerous.”